TSX:RVX Price: $3.56 / -$0.07 Clinical Cardiovascular View animation Learn more Epigenetics Platform Technology View animation Learn more News May 01, 2013 Resverlogix's Board Approves Arrangement to Spin-Out RVX Therapeutics Inc. and Confirms Special Meeting of Shareholders April 18, 2013 Resverlogix Completes Dosing In ASSURE Clinical Trial see all news Blog April 18, 2013 BET-Proteins March 12, 2013 Readers, writers & erasers- what exactly does this mean in epigenetics? see all blog entries